Ingevity Co. (NYSE:NGVT) Shares Purchased by Leeward Investments LLC MA

Leeward Investments LLC MA increased its stake in shares of Ingevity Co. (NYSE:NGVT) by 8.0% during the 4th quarter, Holdings Channel.com reports. The fund owned 189,347 shares of the company’s stock after purchasing an additional 13,984 shares during the quarter. Leeward Investments LLC MA’s holdings in Ingevity were worth $7,716,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. First Horizon Advisors Inc. raised its position in Ingevity by 45.9% in the 3rd quarter. First Horizon Advisors Inc. now owns 862 shares of the company’s stock valued at $34,000 after purchasing an additional 271 shares during the last quarter. KBC Group NV raised its position in Ingevity by 50.8% in the 3rd quarter. KBC Group NV now owns 1,574 shares of the company’s stock valued at $61,000 after purchasing an additional 530 shares during the last quarter. Blue Trust Inc. grew its holdings in shares of Ingevity by 179.6% during the third quarter. Blue Trust Inc. now owns 2,505 shares of the company’s stock worth $98,000 after buying an additional 1,609 shares during the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of Ingevity by 27.3% during the third quarter. Nisa Investment Advisors LLC now owns 3,880 shares of the company’s stock worth $151,000 after buying an additional 831 shares during the last quarter. Finally, Empowered Funds LLC purchased a new position in shares of Ingevity during the fourth quarter worth about $187,000. 91.59% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on NGVT shares. StockNews.com raised Ingevity from a “hold” rating to a “buy” rating in a report on Thursday. BMO Capital Markets upped their price target on Ingevity from $61.00 to $62.00 and gave the stock a “market perform” rating in a research note on Thursday. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $54.67.

Ingevity Stock Down 1.4 %

NGVT opened at $46.11 on Monday. The company has a debt-to-equity ratio of 6.86, a current ratio of 1.87 and a quick ratio of 1.04. Ingevity Co. has a 12 month low of $30.90 and a 12 month high of $56.29. The stock has a market capitalization of $1.68 billion, a P/E ratio of -3.89 and a beta of 1.64. The business has a 50 day simple moving average of $43.33 and a 200-day simple moving average of $41.18.

Ingevity (NYSE:NGVT) last released its earnings results on Tuesday, February 18th. The company reported $0.95 EPS for the quarter, beating analysts’ consensus estimates of $0.29 by $0.66. The company had revenue of $298.80 million during the quarter, compared to the consensus estimate of $297.40 million. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. On average, equities analysts anticipate that Ingevity Co. will post 4.45 earnings per share for the current fiscal year.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.